Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  880 results for ""Biphenyl Compounds""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phase III randomized clinical trial of efficacy and safety of amlodipine and candesartan cilexetil combination for hypertension treatment.

  • Authors : Soh MS; Department of Cardiology, Ajou University School of Medicine, 164 Worldcup-ro, Yeongtong-gu, Suwon, 16499, Republic of Korea.; Won KH

Subjects: Amlodipine*/Amlodipine*/Amlodipine*/administration & dosage ; Amlodipine*/Amlodipine*/Amlodipine*/adverse effects ; Amlodipine*/Amlodipine*/Amlodipine*/therapeutic use

  • Source: Scientific reports [Sci Rep] 2024 Oct 03; Vol. 14 (1), pp. 22940. Date of Electronic Publication: 2024 Oct 03.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial.

  • Authors : Shin DH; Department of Neurology, Gil Medical Center, Gachon University College of Medicine, Incheon, Republic of Korea.; Song S

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*therapeutic use ; Blood Pressure/Blood Pressure/Blood Pressure/*drug effects

  • Source: Cardiovascular therapeutics [Cardiovasc Ther] 2019 Jun 02; Vol. 2019, pp. 7836527. Date of Electronic Publication: 2019 Jun 02 (Print Publication: 2019).Publisher: Hindawi Country of Publication: England NLM ID: 101319630 Publication Model: eCollection Cited Medium: Internet ISSN: 1755-5922

Record details

×
Academic Journal

Fimasartan reduces clinic and home pulse pressure in elderly hypertensive patients: A K-MetS study.

  • Authors : Cho EJ; Division of Cardiology, St. Paul's Hospital, Catholic University of Korea, Seoul, Korea.; Sung KC

Subjects: Blood Pressure*/Blood Pressure*/Blood Pressure*/drug effects; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*therapeutic use ; Hypertension/Hypertension/Hypertension/*drug therapy

  • Source: PloS one [PLoS One] 2019 Apr 09; Vol. 14 (4), pp. e0214293. Date of Electronic Publication: 2019 Apr 09 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

×
Academic Journal

Design and optimization of candesartan loaded self-nanoemulsifying drug delivery system for improving its dissolution rate and pharmacodynamic potential.

  • Authors : Verma R; Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, Haryana, India.; Kaushik D

Subjects: Drug Design*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*administration & dosage ; Benzimidazoles/Benzimidazoles/Benzimidazoles/*administration & dosage

  • Source: Drug delivery [Drug Deliv] 2020 Dec; Vol. 27 (1), pp. 756-771.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464

Record details

×
Academic Journal

Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.

  • Authors : Dudhipala N; a Department of Nanotechnology , University College of Pharmaceutical Sciences, Kakatiya University , Warangal , Andra Pradesh , India.; Veerabrahma K

Subjects: Drug Carriers* ; Nanoparticles*; Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*administration & dosage

  • Source: Drug delivery [Drug Deliv] 2016; Vol. 23 (2), pp. 395-404. Date of Electronic Publication: 2014 May 28.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Efficacy and safety of two single-pill fixed-dose combinations of angiotensin II receptor blockers/calcium channel blockers in hypertensive patients (EXAMINER study).

  • Authors : Motozato K; a Department of Cardiology , Fukuoka University School of Medicine , Fukuoka , Japan .; c Department of Molecular Cardiovascular Therapeutics , Fukuoka University School of Medicine , Fukuoka , Japan .

Subjects: Amlodipine*/Amlodipine*/Amlodipine*/administration & dosage ; Amlodipine*/Amlodipine*/Amlodipine*/adverse effects ; Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/administration & dosage

  • Source: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2016; Vol. 38 (1), pp. 45-50. Date of Electronic Publication: 2015 Aug 13.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9305929 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The therapeutic advantage of combination antihypertensive drug therapy using amlodipine and irbesartan in hypertensive patients: Analysis of the post-marketing survey data from PARTNER (Practical combination therapy of Amlodin and angiotensin II Receptor blocker; safety and efficacy in patients with hypertension) study.

  • Authors : Ishimitsu T; a Department of Cardiology and Nephrology , Dokkyo Medical University , Tochigi , Japan and.; Fukuda H

Subjects: Amlodipine*/Amlodipine*/Amlodipine*/administration & dosage ; Amlodipine*/Amlodipine*/Amlodipine*/adverse effects ; Biphenyl Compounds*/Biphenyl Compounds*/Biphenyl Compounds*/administration & dosage

  • Source: Clinical and experimental hypertension (New York, N.Y. : 1993) [Clin Exp Hypertens] 2015; Vol. 37 (7), pp. 542-50. Date of Electronic Publication: 2015 May 15.Publisher: Informa Healthcare Country of Publication: England NLM ID: 9305929 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Candesartan cilexetil 32 mg/hydrochlorothiazide 25 mg in unselected patients with high or very high cardiovascular risk: efficacy, safety, and metabolic impact.

  • Authors : Bramlage P; Institut für Pharmakologie und präventive Medizin, Menzelstrasse 21, 15831, Mahlow, Germany, .; Buhck H

Subjects: Antihypertensive Agents*/Antihypertensive Agents*/Antihypertensive Agents*/administration & dosage ; Antihypertensive Agents*/Antihypertensive Agents*/Antihypertensive Agents*/adverse effects ; Antihypertensive Agents*/Antihypertensive Agents*/Antihypertensive Agents*/pharmacology

  • Source: Clinical drug investigation [Clin Drug Investig] 2014 Apr; Vol. 34 (4), pp. 241-9.Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The role of irbesartan in the treatment of patients with hypertension: a comprehensive and practical review.

  • Authors : Borghi C; Department of Medicine, Aging and Clinical Nephrology, University of Bologna, Bologna, Italy. ; Cicero AF

Subjects: Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/Angiotensin II Type 1 Receptor Blockers/*therapeutic use ; Antihypertensive Agents/Antihypertensive Agents/Antihypertensive Agents/*therapeutic use ; Biphenyl Compounds/Biphenyl Compounds/Biphenyl Compounds/*therapeutic use

  • Source: High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension [High Blood Press Cardiovasc Prev] 2012 Mar Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9421087 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  880 results for ""Biphenyl Compounds""